A Method for Developing Rapid Screening Values for Active Pharmaceutical Ingredients (APIs) in Water and Results of Initial Application for 119 APIs

Americans fill upward of four billion prescriptions for pharmaceuticals each year, and many of those pharmaceuticals eventually make their way into the environment. Hundreds of different active pharmaceutical ingredients (APIs) are detected in ambient waters and source water used for drinking water...

Full description

Bibliographic Details
Main Authors: Ashley Suchomel, Helen Goeden, Julia Dady
Format: Article
Language:English
Published: MDPI AG 2018-06-01
Series:International Journal of Environmental Research and Public Health
Subjects:
LTD
Online Access:http://www.mdpi.com/1660-4601/15/7/1308
id doaj-548eb155716548eaa56206596636f2f8
record_format Article
spelling doaj-548eb155716548eaa56206596636f2f82020-11-24T23:16:16ZengMDPI AGInternational Journal of Environmental Research and Public Health1660-46012018-06-01157130810.3390/ijerph15071308ijerph15071308A Method for Developing Rapid Screening Values for Active Pharmaceutical Ingredients (APIs) in Water and Results of Initial Application for 119 APIsAshley Suchomel0Helen Goeden1Julia Dady2Minnesota Department of Health, Saint Paul, MN 55164, USAMinnesota Department of Health, Saint Paul, MN 55164, USAMinnesota Department of Health, Saint Paul, MN 55164, USAAmericans fill upward of four billion prescriptions for pharmaceuticals each year, and many of those pharmaceuticals eventually make their way into the environment. Hundreds of different active pharmaceutical ingredients (APIs) are detected in ambient waters and source water used for drinking water in the U.S. Very few of these drugs have health-based guidance values that suggest a safe level for individuals exposed in the ambient environment through drinking water. The Minnesota Department of Health (MDH) has developed a novel method to derive screening-level human health guidance values for APIs. This method was designed for rapid evaluation and relies on Food and Drug Administration (FDA)-approved drug labels and limited additional public data resources for necessary information. MDH developed an analytical framework using traditional and novel uncertainty and adjustment factors specific to the information available for APIs. This framework, along with an estimated lowest therapeutic dose (LTD), was used to derive screening reference dose (sRfD) values. Water screening values (WSV) were then derived using the sRfD, a relative source contribution factor (RSC), and a water intake rate for infants to represent a highly exposed population. MDH used this new method to derive water screening values for 119 APIs that are commonly prescribed and/or commonly monitored in Minnesota waters, including antibiotics, antidepressants, steroids, and other classes of drugs. The derived WSVs can be used to provide context to environmental detections, prioritize APIs for further health-based guidance development, prioritize APIs for future environmental monitoring studies, and inform the development or refinement of analytical methods.http://www.mdpi.com/1660-4601/15/7/1308pharmaceuticalshuman healthenvironmentdrug labelsscreening methodLTDuncertainty factorsrisk assessmentrisk context
collection DOAJ
language English
format Article
sources DOAJ
author Ashley Suchomel
Helen Goeden
Julia Dady
spellingShingle Ashley Suchomel
Helen Goeden
Julia Dady
A Method for Developing Rapid Screening Values for Active Pharmaceutical Ingredients (APIs) in Water and Results of Initial Application for 119 APIs
International Journal of Environmental Research and Public Health
pharmaceuticals
human health
environment
drug labels
screening method
LTD
uncertainty factors
risk assessment
risk context
author_facet Ashley Suchomel
Helen Goeden
Julia Dady
author_sort Ashley Suchomel
title A Method for Developing Rapid Screening Values for Active Pharmaceutical Ingredients (APIs) in Water and Results of Initial Application for 119 APIs
title_short A Method for Developing Rapid Screening Values for Active Pharmaceutical Ingredients (APIs) in Water and Results of Initial Application for 119 APIs
title_full A Method for Developing Rapid Screening Values for Active Pharmaceutical Ingredients (APIs) in Water and Results of Initial Application for 119 APIs
title_fullStr A Method for Developing Rapid Screening Values for Active Pharmaceutical Ingredients (APIs) in Water and Results of Initial Application for 119 APIs
title_full_unstemmed A Method for Developing Rapid Screening Values for Active Pharmaceutical Ingredients (APIs) in Water and Results of Initial Application for 119 APIs
title_sort method for developing rapid screening values for active pharmaceutical ingredients (apis) in water and results of initial application for 119 apis
publisher MDPI AG
series International Journal of Environmental Research and Public Health
issn 1660-4601
publishDate 2018-06-01
description Americans fill upward of four billion prescriptions for pharmaceuticals each year, and many of those pharmaceuticals eventually make their way into the environment. Hundreds of different active pharmaceutical ingredients (APIs) are detected in ambient waters and source water used for drinking water in the U.S. Very few of these drugs have health-based guidance values that suggest a safe level for individuals exposed in the ambient environment through drinking water. The Minnesota Department of Health (MDH) has developed a novel method to derive screening-level human health guidance values for APIs. This method was designed for rapid evaluation and relies on Food and Drug Administration (FDA)-approved drug labels and limited additional public data resources for necessary information. MDH developed an analytical framework using traditional and novel uncertainty and adjustment factors specific to the information available for APIs. This framework, along with an estimated lowest therapeutic dose (LTD), was used to derive screening reference dose (sRfD) values. Water screening values (WSV) were then derived using the sRfD, a relative source contribution factor (RSC), and a water intake rate for infants to represent a highly exposed population. MDH used this new method to derive water screening values for 119 APIs that are commonly prescribed and/or commonly monitored in Minnesota waters, including antibiotics, antidepressants, steroids, and other classes of drugs. The derived WSVs can be used to provide context to environmental detections, prioritize APIs for further health-based guidance development, prioritize APIs for future environmental monitoring studies, and inform the development or refinement of analytical methods.
topic pharmaceuticals
human health
environment
drug labels
screening method
LTD
uncertainty factors
risk assessment
risk context
url http://www.mdpi.com/1660-4601/15/7/1308
work_keys_str_mv AT ashleysuchomel amethodfordevelopingrapidscreeningvaluesforactivepharmaceuticalingredientsapisinwaterandresultsofinitialapplicationfor119apis
AT helengoeden amethodfordevelopingrapidscreeningvaluesforactivepharmaceuticalingredientsapisinwaterandresultsofinitialapplicationfor119apis
AT juliadady amethodfordevelopingrapidscreeningvaluesforactivepharmaceuticalingredientsapisinwaterandresultsofinitialapplicationfor119apis
AT ashleysuchomel methodfordevelopingrapidscreeningvaluesforactivepharmaceuticalingredientsapisinwaterandresultsofinitialapplicationfor119apis
AT helengoeden methodfordevelopingrapidscreeningvaluesforactivepharmaceuticalingredientsapisinwaterandresultsofinitialapplicationfor119apis
AT juliadady methodfordevelopingrapidscreeningvaluesforactivepharmaceuticalingredientsapisinwaterandresultsofinitialapplicationfor119apis
_version_ 1725587980800753664